1461048792-95c65dc0-f70c-42f9-b343-32f7658c479f

1. A surface coordinate measuring device, comprising a handheld housing (9); computing means (8) in the handheld housing (9); a positioning device (2) for positioning the coordinate measuring device (1) at a surface point (P) on a wall surface (3); a display device (6) for displaying a measurement calculated by the computing means (8); an electronic distance measuring system (7) for determining a longitudinal distance along a longitudinal measurement direction; and transverse measuring means for additional determination of a transverse distance along a transverse measurement direction oriented transverse to the longitudinal measurement direction.
2. A surface coordinate measuring device according to claim 1, wherein the distance measuring system (7) is formed as a laser distance measuring system.
3. A surface coordinate measuring device according to claim 1 wherein the transverse measuring means is a double electronic distance measuring system (7) whose respective measurement directions (M) form a 90-degree angle (\u03a6) relative to one another.
4. A surface coordinate measuring device according to claim 1, wherein the transverse measuring device is a switching mechanism which deflects the measurement direction (M) at least at an angle (\u03a6) of 90\xb0.
5. A surface coordinate measuring device according to claim 1, wherein the transverse measuring device is a swiveling device which swivels the measurement direction (M) in a controlled manner at least by an angle (\u03a6) of 90\xb0.
6. A surface coordinate measuring device according to claim 1, further comprising at least one level sensor (15) sensitive to a gravitational acceleration and which enables horizontal or vertical orientation of a measurement direction (M).
7. A surface coordinate measuring device according to claim 6, wherein the leveling sensor (15) is connected to the computing means (8) in a regulating manner.
8. A surface coordinate measuring device according to claim 1, wherein the display device (6) comprises at least a numerical display for an X coordinate value and a Y coordinate value.
9. A surface coordinate measuring device according to claim 1, further comprising placement means for placing the coordinate measuring device (1) on the wall surface (3) in a securely positioned manner.
10. A surface coordinate measuring device according to claim 9, wherein the placement means comprises three spacers (10) which are spaced apart over the surface and project out from the housing (9) perpendicular to both longitudinal and transverse measurement directions.
11. A surface coordinate measuring device according to claim 1, wherein the positioning device (2) is formed as a marking contour.
12. A surface coordinate measuring device according to claim 1, comprising storage means (20) for storing at least coordinate values and associated with the computing means (8).
13. A surface coordinate measuring device according to claim 1, comprising a marking device (21) for carrying out marking on the wall surface (3).
14. A coordinate measuring device according to claim 13, wherein the marking device (21) is connected in a controlled manner to the computing means (8) and is capable of compensating a positioning error of the housing (9) within a tolerance range.
15. A surface coordinate measuring device according to claim 1, comprising a data transmission interface (23) connected at least to the computing means (8).
16. A surface coordinate measuring device according to claim 1 comprising a mechanical fastening interface (16) for connecting the coordinate measuring device with a handheld power tool (17), with the working tool for working the wall surface serving as the marking implement (11) arranged at the positioning device (2).
17. A measurement method of measuring surface coordinates (X, Y) of a surface point (P) on a wall surface (3) with a surface coordinate measuring device (1) including a handheld housing (9); computing means (8) in the handheld housing (9); a positioning device (2) for positioning the coordinate measuring device (1) at a surface point (P) on a wall surface (3); a display device (6) for displaying a measurement calculated by the computing means (8); an electronic distance measuring system (7) for determining a longitudinal distance along a longitudinal measurement direction; and transverse measuring means for additional determination of a transverse distance along a transverse measurement direction oriented transverse to the longitudinal measurement direction, the method comprising the step of providing the computing means (8) having a program-controlled algorithm (27) which carries out a longitudinal distance measurement relative to a measuring point (P) along the longitudinal measurement direction and the transverse distance measurement relative to a measuring point (5) along the transverse measurement direction in a measurement step (29) and, in a subsequent calculation step (30), determines local surface coordinates (X, Y) of the positioning point (P) from measurement values of the longitudinal distance measurement and the transverse distance measurement.
18. A measuring method according to claim 17, wherein the measurement step (29) comprises carrying out a sequence of a plurality of individual measurements relative to the measurement directions (M) that are offset at different angles for the longitudinal distance measurement and transverse distance measurement with a controlled swiveling device, detecting longitudinal distances and transverse distances, and communicating a minimum longitudinal distance (r0Y) and a minimal transverse distance (r0X), which are determined from the longitudinal distances and transverse distances, to the calculation step (31) for determining the surface coordinates (X, Y).
19. A measuring method according to claim 18, wherein the measurement step (29) comprises carrying out only a limited quantity of individual measurements for the longitudinal measurement direction and transverse measurement direction, respectively, in measurement directions (M) which are offset on both sides at different angles within a narrow angular range.
20. A measuring method according to claim 18, wherein the measurement step (29) comprises detecting and storing pairs of measurement values associated with the individual measurements which are available for a subsequent measurement signal processing step (31) for determining a minimum distance (r0) and a longitudinal perpendicular angle (\u03a60).
21. A measuring method according to claim 20, wherein the measurement signal processing step (31) comprises approximating the pairs of measurement values as a function of the distance (r) which represents a quadratic function of the angle (\u03a6).
22. A measuring method according to claim 18, wherein the calculation step (30) comprises a coordinate transformation step (32) for determining from the minimum longitudinal distance (r0Y) and minimum transverse distance (r0X), a longitudinal perpendicular angle (\u03a60Y) and a transverse perpendicular angle (\u03a60X), and a device-oriented position offset (z), by which the positioning device (2) is offset relative to a geometric intersection of the measurement directions (M), by means of trigonometric functions, the surface coordinates (X,Y) of the positioning device (2).

The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.

What I claim is:

1. A therapy pack for providing a prescribed combined daily oral dose of muscle relaxant drug tablets or capsules and a nonsteroidal anti-inflammatory drug (NSAID) capsules or tablets, comprising:
a blister card including at least one pair of blister cells, with each pair including one cell for containing a prescribed single oral dose strength of said muscle relaxant, and one cell for containing a prescribed single oral dose strength of said NSAID for providing a combined dose thereof at a given time.
2. The therapy pack of claim 1, further including a plurality of said blister cards for providing a prescribed multiple day treatment.
3. The therapy pack of claim 2, wherein said muscle relaxant drug is cyclobenzaprine hydrochloride, and said NSAID is etodolac.
4. The therapy pack of claim 2, further including a carton for containing said plurality of said blister cards for individual disbursement for each daily or day’s treatment.
5. The therapy pack of claim 1, wherein three of said pairs of blister cells are provided, with each being designated by indicia on the associated blister card for morning, afternoon, and bedtime combined doses, respectively.
6. The therapy pack of claim 5, wherein each of said three pairs of blister cells are arranged in three successive rows.
7. The therapy pack of claim 6, wherein each blister cell of each pair of blister cells is arranged in a column, thereby forming first and second spaced apart columns.
8. The therapy pack of claim 7, wherein said muscle relaxant drug is cyclobenzaprine hydrochloride, and said NSAID is etodolac.
9. The therapy pack of claim 8, wherein said first and second columns are labeled via indicia on said blister card as Cyclobenzaprine, and Etodolac, respectively.
10. The therapy pack of claim 7, wherein it is further indicated by indicia that each blister cell of said first column contains 10 milligrams of cyclobenzaprine, and of said second column contains 330 milligrams of etodolac.
11. The therapy pack of claim 3, wherein 10 milligrams is the prescribed single dose of cyclobenzaprine hydrochloride, and 330 milligrams is the prescribed single dose of etodolac.
12. A blister card for providing a single days prescribed multiple and time separated combined doses of muscle relaxant drug tablets, and nonsteroidal anti-inflammatory drug (NSAID) capsules or tablets, comprising:
a plurality of pairs of blister cells arranged into first and second columns and a plurality of rows;
said first column of blister cells each containing a single dose tablet or capsule of muscle relaxant; and
said second column of blister cells each containing a single dose tablet or capsule of NSAID.
13. The blister card of claim 12, wherein said muscle relaxant drug is cyclobenzaprine hydrochloride, and said NSAID capsule or tablet is etodolac.
14. The blister card of claim 12, wherein said first column of blister cells is identified by indicia thereon as each containing Cyclobenzaprine 10 mg, and said second column is identified by indicia thereon as each containing Etodolac 330 mg.
15. The blister card of claim 12, wherein first and second columns of blister cells are spaced apart, and said plurality of pairs of blister cells are arranged into three rows labeled by indicia as MORNING, AFTERNOON, and BEDTIME, respectively.
16. The blister card of claim 14, wherein said first and second columns of blister cells are spaced apart, and said plurality of pairs of blister cells are arranged into three rows labeled by indicia as MORNING, AFTERNOON, and BEDTIME, respectively.
17. A therapy pack for providing a prescribed combined daily oral dose of tablets or capsules of the muscle relaxant drug cyclobenzaprine, and the nonsteroidal anti-inflammatory drug (NSAID) etodolac comprising:
a blister card including at least one pair of blister cells, with each pair including one cell for containing a prescribed single oral dose strength of said muscle relaxant and one cell for containing a prescribed single oral dose strength of said NSAID for providing a combined dose thereof at a given time.
18. The therapy pack of claim 17, further including a plurality of said blister cards for providing a prescribed multiple day treatment.
19. The therapy pack of claim 18, further including a carton for containing said plurality of said blister cards for individual disbursement for each daily or day’s treatment.
20. The therapy pack of claim 17, wherein said three pairs of blister cells are designated by indicia printed on the associated blister card for identifying morning, afternoon, and bedtime combined doses, respectively.
21. The therapy pack of claim 20, wherein each of said three pairs of blister cells are arranged in three successive rows.
22. The therapy pack of claim 21, wherein each blister cell of each pair of blister cells is arranged in a column, thereby forming first and second spaced apart columns.
23. The therapy pack of claim 22, wherein said first and second columns are labeled via indicia on said blister card as cyclobenzaprine and etodolac, respectively.
24. The therapy pack of claim 23, wherein it is further indicated by said indicia that each blister cell of said first column contains a 10 milligram dose of cyclobenzaprine, and each blister cell of said second column contains a 330 milligram dose of etodolac.
25. The therapy pack of claim 17, wherein 10 milligrams is the prescribed single dose of cyclobenzaprine hydrochloride, and 330 milligrams is the prescribed single dose of etodolac.
26. A blister card for providing a single days prescribed three time separated combined doses of cyclobenzaprine hydrochloride capsules or tablets, and etodolac capsules or tablets, comprising:
three pairs of blister cells arranged into first and second columns and three rows;
said first column of blister cells each containing a single dose tablet or capsule of cyclobenzaprine hydrochloride; and
said second column of blister cells each containing a single dose tablet or capsule of etodolac.
27. The blister card of claim 26, wherein a single dose tablet of cyclobenzaprine hydrochloride contains 10 milligrams thereof, and a single dose capsule or tablet of etodolac contains 330 milligrams thereof.
28. The blister card of claim 26, wherein said first column of blister cells is identified by indicia thereon as each containing Cyclobenzaprine 10 mg, and a second column is identified by indicia thereon as each containing Etodolac 330 mg.
29. The blister card of claim 26, wherein said columns of blister cells are spaced apart, and each of said three rows are labeled by indicia as MORNING, AFTERNOON, and BEDTIME, respectively.
30. The blister card of claim 28, wherein said columns of blister cells are spaced apart, and each of said three rows are labeled by indicia as MORNING, AFTERNOON, and BEDTIME, respectively.